GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Sequenom Inc (FRA:QNMA) » Definitions » ROA %

Sequenom (FRA:QNMA) ROA % : -24.87% (As of Jun. 2016)


View and export this data going back to . Start your Free Trial

What is Sequenom ROA %?

ROA % is calculated as Net Income divided by its average Total Assets over a certain period of time. Sequenom's annualized Net Income for the quarter that ended in Jun. 2016 was €-22.5 Mil. Sequenom's average Total Assets over the quarter that ended in Jun. 2016 was €90.3 Mil. Therefore, Sequenom's annualized ROA % for the quarter that ended in Jun. 2016 was -24.87%.

The historical rank and industry rank for Sequenom's ROA % or its related term are showing as below:

FRA:QNMA's ROA % is not ranked *
in the Biotechnology industry.
Industry Median: -35.41
* Ranked among companies with meaningful ROA % only.

Sequenom ROA % Historical Data

The historical data trend for Sequenom's ROA % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sequenom ROA % Chart

Sequenom Annual Data
Trend Dec06 Dec07 Dec08 Dec09 Dec10 Dec11 Dec12 Dec13 Dec14 Dec15
ROA %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -47.34 -60.26 -53.10 0.69 -12.51

Sequenom Quarterly Data
Sep11 Dec11 Mar12 Jun12 Sep12 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16
ROA % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -25.08 -28.47 -39.92 -47.60 -24.87

Competitive Comparison of Sequenom's ROA %

For the Biotechnology subindustry, Sequenom's ROA %, along with its competitors' market caps and ROA % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sequenom's ROA % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Sequenom's ROA % distribution charts can be found below:

* The bar in red indicates where Sequenom's ROA % falls into.



Sequenom ROA % Calculation

Sequenom's annualized ROA % for the fiscal year that ended in Dec. 2015 is calculated as:

ROA %=Net Income (A: Dec. 2015 )/( (Total Assets (A: Dec. 2014 )+Total Assets (A: Dec. 2015 ))/ count )
=-14.992/( (130.629+109.042)/ 2 )
=-14.992/119.8355
=-12.51 %

Sequenom's annualized ROA % for the quarter that ended in Jun. 2016 is calculated as:

ROA %=Net Income (Q: Jun. 2016 )/( (Total Assets (Q: Mar. 2016 )+Total Assets (Q: Jun. 2016 ))/ count )
=-22.452/( (93.945+86.623)/ 2 )
=-22.452/90.284
=-24.87 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual ROA %, the net income of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Net Income data used here is four times the quarterly (Jun. 2016) net income data. ROA % is displayed in the 30-year financial page.


Sequenom  (FRA:QNMA) ROA % Explanation

ROA % measures the rate of return on the total assets (shareholder equity plus liabilities). It measures a firm's efficiency at generating profits from shareholders' equity plus its liabilities. ROA % shows how well a company uses what it has to generate earnings. ROA %s can vary drastically across industries. Therefore, ROA % should not be used to compare companies in different industries. For retailers, a ROA % of higher than 5% is expected. For example, Wal-Mart (WMT) has a ROA % of about 8% as of 2012. For banks, ROA % is close to their interest spread. A bank’s ROA % is typically well under 2%.

Similar to ROE, ROA % is affected by profit margins and asset turnover. This can be seen from the Du Pont Formula:

ROA %(Q: Jun. 2016 )
=Net Income/Total Assets
=-22.452/90.284
=(Net Income / Revenue)*(Revenue / Total Assets)
=(-22.452 / 104.26)*(104.26 / 90.284)
=Net Margin %*Asset Turnover
=-21.53 %*1.1548
=-24.87 %

Note: The Net Income data used here is four times the quarterly (Jun. 2016) net income data. The Revenue data used here is four times the quarterly (Jun. 2016) revenue data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Like ROE, ROA % is calculated with only 12 months data. Fluctuations in the company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. ROA % can be affected by events such as stock buyback or issuance, and by goodwill, a company's tax rate and its interest payment. ROA % may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).

Many analysts argue the higher return the better. Buffett states that really high ROA % may indicate vulnerability in the durability of the competitive advantage.

E.g. Raising $43b to take on KO is impossible, but $1.7b to take on Moody's is. Although Moody's ROA % and underlying economics is far superior to Coca Cola, the durability is far weaker because of lower entry cost.


Sequenom ROA % Related Terms

Thank you for viewing the detailed overview of Sequenom's ROA % provided by GuruFocus.com. Please click on the following links to see related term pages.


Sequenom (FRA:QNMA) Business Description

Traded in Other Exchanges
N/A
Address
Sequenom Inc was incorporated in 1994 under the laws of the State of Delaware. It is a life science company providing revolutionary genomic and genetic analysis solutions for the molecular diagnostic and clinical research markets. It develop and commercialize molecular diagnostics testing services that target and serve molecular diagnostics markets, and also develop and commercialize research use genetic analysis products and services that target and serve discovery and clinical research markets. It offers its services and products in the United States and international emphasis in countries like European and Asia-Pacific regions. The Company operates in two operating segments; Sequenom Laboratories and Sequenom Bioscience. Sequenom Laboratories provides molecular based, laboratory developed tests, or LDTs, with a focus principally on prenatal diseases and conditions and ophthalmological diseases and conditions. Sequenom Bioscience provides technology and research tools for genetic analysis and applications in translational research, clinical research, pharmacogenomics, oncology, and agricultural genomics. The Company's competitors include; Ariosa Diagnostics, Inc., Beijing Genomics Institute, Cellscape Corp., Celula Inc., Ikonysis, Inc., Kellbenx, Inc., Laboratory Corporation of America Holdings, Inc., Natera, Perkin Elmer, Inc., Quest Laboratories, Verinata and others. Its patent portfolio, including in-licensed patent rights, includes approximately 638 issued or allowed patents in the United States and other industrial nations throughout the world. Its prenatal diagnostic patent portfolio includes exclusive rights to numerous in-licensed issued patents. The Company is subject to federal, state and local laws and regulations governing the use, storage, handling and disposal of such materials and chemicals, as well as certain waste products.

Sequenom (FRA:QNMA) Headlines

No Headlines